Nursing care
Naloxone vs flumazenil: matching the antidote, re-sedation and seizure risk
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
Naloxone reverses opioids; flumazenil reverses benzodiazepines, and neither reverses the other class. Both can wear off before the sedating drug does, so the patient needs continued monitoring for re-sedation. Flumazenil carries a boxed warning for seizures, especially in benzodiazepine-dependent patients or after tricyclic antidepressant overdose, which limits its use in undifferentiated overdose.
Match the antidote to the drug class first
The most important distinction is the target. Naloxone blocks opioid receptors and reverses opioid respiratory depression and sedation, including from fentanyl, morphine, methadone and some mixed agonist-antagonists. Flumazenil blocks the benzodiazepine site on GABA receptors and reverses sedation from drugs such as midazolam and lorazepam. The flumazenil label states plainly that it does not reverse opioids.
In an exam item, read the medication list before choosing. A patient given hydromorphone after surgery with slow breathing and pinpoint pupils fits naloxone. A patient who received midazolam for a procedure and remains oversedated fits flumazenil. If both drug classes were given, the clinical picture and the prescriber's plan decide, and breathing support comes first either way.
Re-sedation affects both agents
Each antidote can wear off before the drug it is reversing. The naloxone label warns that some opioids last longer than naloxone, so the patient needs continued surveillance and repeat doses may be needed. CDC advises staying with a person given naloxone for overdose until help arrives or for at least four hours.
Flumazenil re-sedation was reported in a minority of patients, more often after high benzodiazepine doses or general anaesthesia, and the label advises monitoring for up to about two hours depending on the benzodiazepine given. The label also notes flumazenil has not been established as a treatment for hypoventilation, so airway and ventilatory support remain the priority.
Why flumazenil is used cautiously
Flumazenil has a boxed warning: abrupt reversal can provoke seizures in high-risk patients. Risk factors listed include long-term benzodiazepine use or dependence, recent repeated doses of intravenous benzodiazepines, a history of seizures and co-ingestion of tricyclic antidepressants. It is contraindicated when a benzodiazepine is controlling a life-threatening condition such as status epilepticus or raised intracranial pressure.
That is why flumazenil is more often used to reverse procedural sedation in a patient without dependence than in an unknown mixed overdose. In the overdose setting, supportive airway and breathing care is generally preferred. Have seizure precautions and suction available whenever it is given.
Naloxone adverse effects to anticipate
In a person physically dependent on opioids, naloxone can trigger acute withdrawal: nausea, vomiting, sweating, tremor, tachycardia, agitation and pain. After surgery, abrupt full reversal can cause severe pain and, rarely, serious cardiovascular effects such as arrhythmias and pulmonary oedema. That is why postoperative reversal is often titrated in small increments to restore breathing rather than full alertness.
Reversal of buprenorphine may be incomplete, and ventilatory support may be needed. Naloxone causes no harm when the cause of sedation is not an opioid, so it can reasonably be given in a suspected overdose of unknown cause, but it will not reverse benzodiazepines, alcohol or xylazine.
Worked study scenario
Consider a hypothetical patient two hours after a colonoscopy with midazolam and fentanyl. Respiratory rate is 7, saturation is falling and the patient responds only to pain. Options include giving flumazenil first, stimulating and supporting ventilation while giving naloxone as ordered, or waiting thirty minutes to see if sedation lifts. Supporting breathing and giving naloxone is strongest.
Respiratory depression is the dominant threat, and opioids are the main driver of slowed breathing, so naloxone addresses it most directly. Flumazenil may be considered afterwards if benzodiazepine sedation persists and no seizure risk factors exist. Waiting is unsafe. Whatever is given, continued monitoring follows because either drug can outlast its antidote.
Sources and further reading
DailyMed: Flumazenil injection prescribing information. Boxed seizure warning, risk factors, no opioid reversal, re-sedation and monitoring period, contraindications.
DailyMed: Naloxone hydrochloride injection prescribing information. Indications, shorter duration than some opioids, withdrawal, postoperative reversal effects and incomplete buprenorphine reversal.
CDC: Lifesaving naloxone. Repeat doses with potent opioids, staying with the person for monitoring, and no harm in non-opioid overdose.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Will naloxone reverse a benzodiazepine overdose?
No. Naloxone acts only on opioid receptors. It is still reasonable in a suspected overdose of unknown cause because it does no harm if opioids are not involved, but benzodiazepine sedation needs airway support and possibly flumazenil.
Why can a patient become drowsy again after naloxone?
Many opioids last longer than naloxone. When the naloxone wears off, the remaining opioid can depress breathing again, so monitoring continues and repeat doses may be needed.
Who is at highest risk of seizures from flumazenil?
The label highlights patients dependent on benzodiazepines, those given repeated intravenous benzodiazepines recently, people with a seizure history and those who took tricyclic antidepressants.
More on pharmacology
Guides on this